Cargando…
Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
The formation of calixarene-based liposomes was investigated, and the characterization of these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the polar group pre...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398082/ https://www.ncbi.nlm.nih.gov/pubmed/34452211 http://dx.doi.org/10.3390/pharmaceutics13081250 |
_version_ | 1783744753046650880 |
---|---|
author | Lebrón, José Antonio López-López, Manuel García-Calderón, Clara B. V. Rosado, Ivan Balestra, Fernando R. Huertas, Pablo Rodik, Roman V. Kalchenko, Vitaly I. Bernal, Eva Moyá, María Luisa López-Cornejo, Pilar Ostos, Francisco J. |
author_facet | Lebrón, José Antonio López-López, Manuel García-Calderón, Clara B. V. Rosado, Ivan Balestra, Fernando R. Huertas, Pablo Rodik, Roman V. Kalchenko, Vitaly I. Bernal, Eva Moyá, María Luisa López-Cornejo, Pilar Ostos, Francisco J. |
author_sort | Lebrón, José Antonio |
collection | PubMed |
description | The formation of calixarene-based liposomes was investigated, and the characterization of these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the polar group present in the upper rim of the calixarenes were varied. The lipid bilayer was formed with one calixarene and with the phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE. The cytotoxicity of the liposomes for various cell lines was also studied. From the results obtained, the liposomes formed with the least cytotoxic calixarene, (TEAC(12))(4), were used as nanocarriers of both nucleic acids and the antineoplastic drug doxorubicin, DOX. Results showed that (TEAC(12))(4)/DOPE/p-EGFP-C1 lipoplexes, of a given composition, can transfect the genetic material, although the transfection efficiency substantially increases in the presence of an additional amount of DOPE as coadjuvant. On the other hand, the (TEAC(12))(4)/DOPE liposomes present a high doxorubicin encapsulation efficiency, and a slow controlled release, which could diminish the side effects of the drug. |
format | Online Article Text |
id | pubmed-8398082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83980822021-08-29 Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery Lebrón, José Antonio López-López, Manuel García-Calderón, Clara B. V. Rosado, Ivan Balestra, Fernando R. Huertas, Pablo Rodik, Roman V. Kalchenko, Vitaly I. Bernal, Eva Moyá, María Luisa López-Cornejo, Pilar Ostos, Francisco J. Pharmaceutics Article The formation of calixarene-based liposomes was investigated, and the characterization of these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the polar group present in the upper rim of the calixarenes were varied. The lipid bilayer was formed with one calixarene and with the phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE. The cytotoxicity of the liposomes for various cell lines was also studied. From the results obtained, the liposomes formed with the least cytotoxic calixarene, (TEAC(12))(4), were used as nanocarriers of both nucleic acids and the antineoplastic drug doxorubicin, DOX. Results showed that (TEAC(12))(4)/DOPE/p-EGFP-C1 lipoplexes, of a given composition, can transfect the genetic material, although the transfection efficiency substantially increases in the presence of an additional amount of DOPE as coadjuvant. On the other hand, the (TEAC(12))(4)/DOPE liposomes present a high doxorubicin encapsulation efficiency, and a slow controlled release, which could diminish the side effects of the drug. MDPI 2021-08-12 /pmc/articles/PMC8398082/ /pubmed/34452211 http://dx.doi.org/10.3390/pharmaceutics13081250 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lebrón, José Antonio López-López, Manuel García-Calderón, Clara B. V. Rosado, Ivan Balestra, Fernando R. Huertas, Pablo Rodik, Roman V. Kalchenko, Vitaly I. Bernal, Eva Moyá, María Luisa López-Cornejo, Pilar Ostos, Francisco J. Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery |
title | Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery |
title_full | Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery |
title_fullStr | Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery |
title_full_unstemmed | Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery |
title_short | Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery |
title_sort | multivalent calixarene-based liposomes as platforms for gene and drug delivery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398082/ https://www.ncbi.nlm.nih.gov/pubmed/34452211 http://dx.doi.org/10.3390/pharmaceutics13081250 |
work_keys_str_mv | AT lebronjoseantonio multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT lopezlopezmanuel multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT garciacalderonclarab multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT vrosadoivan multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT balestrafernandor multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT huertaspablo multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT rodikromanv multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT kalchenkovitalyi multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT bernaleva multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT moyamarialuisa multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT lopezcornejopilar multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery AT ostosfranciscoj multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery |